Non-steroidal Anti-inflammatory Drugs
Non-steroidal Anti-inflammatory Drugs Market by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases), Drugs (Over-the-counter Drugs, Prescription), Route of Administration, Distribution Channel - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the non-steroidal anti-inflammatory drugs market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[184 Pages Report] The Non-steroidal Anti-inflammatory Drugs Market size was estimated at USD 21.71 billion in 2023 and expected to reach USD 23.24 billion in 2024, at a CAGR 7.53% to reach USD 36.10 billion by 2030.

Non-steroidal anti-inflammatory drugs (NSAIDs) are essential for their analgesic, antipyretic, and anti-inflammatory properties, commonly used to treat conditions including arthritis, muscle pain, and post-operative pain. These drugs are pivotal in managing pain and inflammation without prescription narcotics, catering to a wide range of end-users such as healthcare professionals, hospitals, home care, athletes, and elderly patients. Influencing growth factors include the rising prevalence of chronic diseases, global aging demographics, sedentary lifestyle impacts, and increased availability of over-the-counter drugs. Expanding into emerging markets such as China, India, and Brazil, developing safer NSAIDs, and integrating digital health solutions provide significant opportunities. However, challenges such as gastrointestinal and cardiovascular side effects, stringent regulatory hurdles, and market saturation in developed regions constrain growth. Innovation areas include formulation improvements for minimized side effects, patient-specific therapies, and exploring biological alternatives. The NSAID market, dynamic and competitive, comprises major players, with advancements focused on patient outcomes and safety. Decision-makers should invest in emerging markets, prioritize research and development, and enhance patient education to leverage market opportunities. Strategic investments in innovation, patient education, and geographical expansion will ensure sustainable growth and an enhanced market footprint in the NSAID industry.

Regional Insights

The United States is a critical market for NSAIDs due to high healthcare expenditure, an aging population, and the prevalence of chronic conditions. Canada benefits from a robust healthcare system, an increasing elderly population, and regulatory frameworks, although stringent regulations temper market exuberance. European countries, such as Germany, France, and the United Kingdom, demonstrate robust demand, emphasizing patient safety and pharmacovigilance. Japan exhibits a stable market driven by its aging population and high healthcare standards. China and India show massive growth potential supported by substantial healthcare reforms and the rising prevalence of chronic diseases, though regulatory challenges persist. In the Middle East, demand grows due to improving healthcare infrastructure, as seen in countries like Saudi Arabia and the UAE. In Africa, South Africa shows better market performance driven by advanced healthcare systems. Major trading countries include the United States, Germany, China, Japan, and India, all significant in global NSAID production and consumption. Recent developments include innovations in sustained-release formulations, personalized medicine approaches, and increased biopharmaceutical R&D investments. Digital health collaborations and global initiatives focus on comprehensive pain management. Decision-makers must navigate regulatory landscapes and focus on research and development to address evolving market demands effectively.

The NSAID market is governed by stringent regulatory frameworks varying by region, ensuring safety and efficacy. The U.S. Food and Drug Administration (FDA) mandates rigorous clinical trials and post-marketing surveillance for NSAIDs, whereas the European Medicines Agency (EMA) emphasizes patient safety through stringent approval processes and periodic safety updates. Health Canada enforces stringent yet transparent regulations, while Japan’s Ministry of Health, Labour and Welfare (MHLW) focuses on extensive clinical data. China’s National Medical Products Administration (NMPA) has reformed its processes to expedite drug approvals. Vendors are adopting strategic moves such as global collaborations, developing innovative formulations, integrating digital health, and expanding into emerging markets. With an aging population and a focus on non-prescription pain management, developed countries should prioritize R&D investments, regulatory navigation, and personalized medicine to maintain market access. Bigger economies can capitalize by investing in innovative research, diversifying markets, educating consumers, and integrating telemedicine platforms. Recent advancements in drug formulations, ongoing research, collaborations with tech firms, and business expansions in emerging markets are shaping the industry. Key events such as regulatory reforms, patent expiries, mergers and acquisitions, and the rise of e-pharmacies and telehealth platforms will significantly impact the NSAID market dynamics.

Non-steroidal Anti-inflammatory Drugs Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Non-steroidal Anti-inflammatory Drugs Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Rise in chronic pain cases and surge in inflammation cases
    • Increasing geriatric population and rising awareness about the use of non-steroidal anti-inflammatory drugs
    • Increasing preference of people for nsaids over opioids
  • Market Restraints
    • Side effects associated with the use of non-steroidal anti-inflammatory drugs
  • Market Opportunities
    • Quick authority approvals by the governments and increase in government initiatives
    • Emerging technology, research and development activities, and launch of novel drugs
  • Market Challenges
    • Failure of drug during the clinical trial
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Non-steroidal Anti-inflammatory Drugs Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Non-steroidal Anti-inflammatory Drugs Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Non-steroidal Anti-inflammatory Drugs Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Non-steroidal Anti-inflammatory Drugs Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Non-steroidal Anti-inflammatory Drugs Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Non-steroidal Anti-inflammatory Drugs Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Non-steroidal Anti-inflammatory Drugs Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Non-steroidal Anti-inflammatory Drugs Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Non-steroidal Anti-inflammatory Drugs Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Non-steroidal Anti-inflammatory Drugs Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

Before using the Non-steroidal Anti-inflammatory Drugs Market Research Report by 360iResearch, we faced significant challenges navigating the complexities of regulatory approvals and understanding government initiatives. The report provided valuable insights and actionable strategies, enabling us to secure quick authority approvals and leverage increased government initiatives effectively. As a result, our operational efficiency improved significantly. We are extremely satisfied with the positive impact this report has had on our organization.
Reckitt Benckiser Group PLC
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Non-steroidal Anti-inflammatory Drugs Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Non-steroidal Anti-inflammatory Drugs Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Non-steroidal Anti-inflammatory Drugs Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

We were facing significant challenges in navigating the complexities of the increasing cases of chronic pain and inflammation. The Non-steroidal Anti-inflammatory Drugs Market Research Report by 360iResearch provided us with invaluable insights and actionable strategies. The detailed analysis and evidence-based recommendations from the report enabled us to enhance our product development and market positioning. Thanks to this comprehensive report, we observed a notable improvement in our market share and customer satisfaction. The positive impact on our operations has been remarkable, and we are extremely satisfied with the results.
Teva Pharmaceutical Industries Ltd.
To learn more about this report, request a free PDF copy
Key Company Profiles

The report delves into recent significant developments in the Non-steroidal Anti-inflammatory Drugs Market, highlighting leading vendors and their innovative profiles. These include Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Sanofi S.A., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Boehringer Ingelheim International GmbH, Apotex Inc., Assertio Therapeutics, Inc., Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Merck & Co., Inc., Johnson & Johnson Services, Inc., and Bayer AG.

Non-steroidal Anti-inflammatory Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Non-steroidal Anti-inflammatory Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Indication
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
  • Drugs
    • Over-the-counter Drugs
      • Aspirin (Bufferin, Bayer, & Excedrin)
      • Ibuprofen (Advil, Motrin, Nuprin)
      • Ketoprofen (Actron, Orudis)
      • Naproxen (Aleve)
    • Prescription
      • Daypro
      • Indocin
      • Lodine
      • Naprosyn
      • Relafen
      • Vimovo
      • Voltaren
  • Route of Administration
    • Oral
    • Parenteral
  • Distribution Channel
    • Drug Store
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Before utilizing the Non-steroidal Anti-inflammatory Drugs Market Research Report by 360iResearch, we faced significant challenges in understanding market trends and consumer preferences. The report provided us with valuable insights and actionable strategies, highlighting the increasing preference for NSAIDs over opioids. This helped us realign our product focus and marketing strategies. Specific findings enabled us to enhance our product offerings, ultimately leading to increased customer satisfaction and market share. We are thoroughly delighted with the profound impact this report has had on our operations at AstraZeneca PLC.
AstraZeneca PLC
To learn more about this report, request a free PDF copy
This research report offers invaluable insights into various crucial aspects of the Non-steroidal Anti-inflammatory Drugs Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
  7. Non-steroidal Anti-inflammatory Drugs Market, by Drugs
  8. Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
  9. Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
  10. Americas Non-steroidal Anti-inflammatory Drugs Market
  11. Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market
  12. Europe, Middle East & Africa Non-steroidal Anti-inflammatory Drugs Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 564]
  17. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the Non-steroidal Anti-inflammatory Drugs Market?
    Ans. The Global Non-steroidal Anti-inflammatory Drugs Market size was estimated at USD 21.71 billion in 2023 and expected to reach USD 23.24 billion in 2024.
  2. What is the Non-steroidal Anti-inflammatory Drugs Market growth?
    Ans. The Global Non-steroidal Anti-inflammatory Drugs Market to grow USD 36.10 billion by 2030, at a CAGR of 7.53%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.